| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068965677 |
| P356 | DOI | 10.2119/MOLMED.2014.00121 |
| P932 | PMC publication ID | 4277550 |
| P698 | PubMed publication ID | 25121719 |
| P50 | author | Charles A. Dinarello | Q834442 |
| P2093 | author name string | Antonio Abbate | |
| Benjamin W Van Tassell | |||
| Stefano Toldo | |||
| Chiara Sonnino | |||
| Amit Varma | |||
| Nayef A Abouzaki | |||
| Claudia Oddi | |||
| Michael L Gambill | |||
| Sanah Christopher | |||
| Raquel Appa Falcao | |||
| Ryan D Melchior | |||
| George H Mueller | |||
| P2860 | cites work | Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group | Q71094855 |
| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group | Q72472826 | ||
| Pilot trials in clinical research: of what value are they? | Q83615967 | ||
| Interleukin-1 in the pathogenesis and treatment of inflammatory diseases | Q24606766 | ||
| Safety of extended treatment with anakinra in patients with rheumatoid arthritis | Q24675209 | ||
| Targeting interleukin-1 in heart disease | Q27009347 | ||
| Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure | Q28731260 | ||
| Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling | Q33862454 | ||
| The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. | Q35621283 | ||
| Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes | Q36109128 | ||
| Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases | Q36816872 | ||
| Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. | Q36816882 | ||
| Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study) | Q36985609 | ||
| Targeting inflammation: impact on atherothrombosis | Q38170328 | ||
| Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction | Q38188327 | ||
| Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group | Q44267568 | ||
| Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. | Q44938264 | ||
| Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). | Q44956453 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| anakinra | Q415411 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 486-489 | |
| P577 | publication date | 2014-11-18 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra | |
| P478 | volume | 20 |
| Q39051784 | Anti-inflammatory drugs as promising cardiovascular treatments. |
| Q89341617 | Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats |
| Q57162899 | Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition |
| Q38805353 | P2X7 receptor inhibition attenuated sympathetic nerve sprouting after myocardial infarction via the NLRP3/IL-1β pathway |
| Q38595544 | Targeting danger-associated molecular patterns after myocardial infarction |
Search more.